Trilostane Patent Expiration

Trilostane was first introduced by Bioenvision Inc in its drug Modrastane on Dec 31, 1984.


About Veterinary Trilostane

Trilostane is used in a drug marketed by 1 company: Dechra Ltd.

Other drugs containing Trilostane are: Vetoryl capsules .

Veterinary Trilostane Patents

Given below is the list of patents protecting Trilostane, along with the drug name that holds that patent and the company owning that drug.

Filter patents by

Drug Used In Drug Patent Number Drug Patent Expiry Drug Owner
Patent Data
VETORYL CAPSULES US9283235 DECHRA, LTD.

Trilostane Petitions

Details of Trilostane's suitability petitions are listed below.

Petitioner Action Date of Action Description
Suitability Petitions
Norbrook Laboratories Limited Approved

Trilostane's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Trilostane Generic API Manufacturers

Given below is the list of companies who have filed for Trilostane generic, along with the locations of their manufacturing plants worldwide.